title: Oxaliplatin-induced hepatoportal sclerosis, portal hypertension, and variceal bleeding successfully treated with transjugular intrahepatic portosystemic shunt.
authors.affiliation: Division of Interventional Radiology and Image-guided Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
authors.forename: Taoreed O
authors.initials: TO
authors.lastname: Lawal
authors.forename: Alton B
authors.initials: AB
authors.lastname: Farris
authors.forename: Bassel F
authors.initials: BF
authors.lastname: El-Rayes
authors.forename: Ram M
authors.initials: RM
authors.lastname: Subramanian
authors.forename: Hyun S
authors.initials: HS
authors.lastname: Kim
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D004932:Esophageal and Gastric Varices / Q000139:chemically induced / Q000601:surgery*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000601:surgery*; D006801:Humans; D006975:Hypertension, Portal / Q000139:chemically induced / Q000601:surgery; D002955:Leucovorin / Q000008:administration & dosage; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077150:Oxaliplatin; D011168:Portal System / Q000473:pathology*; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D012598:Sclerosis / Q000139:chemically induced / Q000150:complications / Q000601:surgery
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D000068258:Bevacizumab; D002955:Leucovorin; D005472:Fluorouracil